12-224018-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016615.5(SLC6A13):c.1285C>A(p.Leu429Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000422 in 1,613,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016615.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A13 | NM_016615.5 | c.1285C>A | p.Leu429Ile | missense_variant | 11/15 | ENST00000343164.9 | NP_057699.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A13 | ENST00000343164.9 | c.1285C>A | p.Leu429Ile | missense_variant | 11/15 | 1 | NM_016615.5 | ENSP00000339260.4 |
Frequencies
GnomAD3 genomes AF: 0.0000397 AC: 6AN: 151252Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251418Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135876
GnomAD4 exome AF: 0.0000424 AC: 62AN: 1461678Hom.: 0 Cov.: 31 AF XY: 0.0000550 AC XY: 40AN XY: 727154
GnomAD4 genome AF: 0.0000396 AC: 6AN: 151374Hom.: 0 Cov.: 33 AF XY: 0.0000406 AC XY: 3AN XY: 73942
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 03, 2023 | The c.1285C>A (p.L429I) alteration is located in exon 11 (coding exon 10) of the SLC6A13 gene. This alteration results from a C to A substitution at nucleotide position 1285, causing the leucine (L) at amino acid position 429 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at